Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods

Volume: 8, Issue: 7, Pages: 381 - 381
Published: Jan 1, 2017
Abstract
To carry out randomized trial for evaluating effects of autologous bone marrow derived stem cell therapy (ABMSCT) through different routes.Bone marrow aspirate was taken from the iliac crest of patients. Bone marrow mononuclear cells were separated and purified using centrifugation. These cells were then infused in a total of 21 patients comprising three groups of 7 patients each. Cells were infused into the superior pancreaticoduodenal artery...
Paper Details
Title
Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods
Published Date
Jan 1, 2017
Volume
8
Issue
7
Pages
381 - 381
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.